Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
SUFZq24sugL7L8zs